8-K
Current Report
Coherus Oncology, Inc. Filed Acc 0001193125-17-214840
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading d405712d8k.htm…